Influence of the IL6 Gene in Susceptibility to Systemic Sclerosis.
(2012) In Journal of Rheumatology- Abstract
- OBJECTIVE: Systemic sclerosis (SSc) is a genetically complex autoimmune disease; the genetic component has not been fully defined. Interleukin 6 (IL-6) plays a crucial role in immunity and fibrosis, both key aspects of SSc. We investigated the influence of IL6 gene in the susceptibility and phenotype expression of SSc. METHODS: We performed a large metaanalysis including a total of 2749 cases and 3189 controls from 6 white populations (Germany, The Netherlands, Norway, Spain, Sweden, and United Kingdom). Three IL6 single-nucleotide polymorphisms (SNP; rs2069827, rs1800795, and rs2069840) were selected by SNP tagging and genotyped using TaqMan® allele discrimination technology. RESULTS: Individual SNP metaanalysis showed no evidence of... (More)
- OBJECTIVE: Systemic sclerosis (SSc) is a genetically complex autoimmune disease; the genetic component has not been fully defined. Interleukin 6 (IL-6) plays a crucial role in immunity and fibrosis, both key aspects of SSc. We investigated the influence of IL6 gene in the susceptibility and phenotype expression of SSc. METHODS: We performed a large metaanalysis including a total of 2749 cases and 3189 controls from 6 white populations (Germany, The Netherlands, Norway, Spain, Sweden, and United Kingdom). Three IL6 single-nucleotide polymorphisms (SNP; rs2069827, rs1800795, and rs2069840) were selected by SNP tagging and genotyped using TaqMan® allele discrimination technology. RESULTS: Individual SNP metaanalysis showed no evidence of association of the 3 IL6 genetic variants with the global disease. Phenotype analyses revealed a significant association between the minor allele of rs2069840 and the limited cutaneous SSc clinical form (Bonferroni p = 0.036, OR 1.14, 95% CI 1.04-1.25). A trend of association between the minor allele of the rs1800795 and the diffuse cutaneous SSc clinical form was also evident (Bonferroni p = 0.072, OR 0.86, 95% CI 0.77-0.96). In the IL6 allelic combination analyses, the GGC allelic combination rs2069827-rs1800795-rs2069840 showed an association with overall SSc (Bonferroni p = 0.016, OR 1.13, 95% CI 1.04-1.23). CONCLUSION: Our results suggest that the IL6 gene may influence the development of SSc and its progression. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/3161301
- author
- organization
- publishing date
- 2012-10-01
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Journal of Rheumatology
- publisher
- Journal of Rheumatology Publishing Company Limited
- external identifiers
-
- wos:000312355400010
- pmid:23027890
- scopus:84870315000
- ISSN
- 0315-162X
- DOI
- 10.3899/jrheum.120506
- language
- English
- LU publication?
- yes
- id
- a065cf22-3974-434e-876f-9395a6cb1eaf (old id 3161301)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/23027890?dopt=Abstract
- date added to LUP
- 2016-04-04 07:32:18
- date last changed
- 2022-04-07 22:46:33
@article{a065cf22-3974-434e-876f-9395a6cb1eaf, abstract = {{OBJECTIVE: Systemic sclerosis (SSc) is a genetically complex autoimmune disease; the genetic component has not been fully defined. Interleukin 6 (IL-6) plays a crucial role in immunity and fibrosis, both key aspects of SSc. We investigated the influence of IL6 gene in the susceptibility and phenotype expression of SSc. METHODS: We performed a large metaanalysis including a total of 2749 cases and 3189 controls from 6 white populations (Germany, The Netherlands, Norway, Spain, Sweden, and United Kingdom). Three IL6 single-nucleotide polymorphisms (SNP; rs2069827, rs1800795, and rs2069840) were selected by SNP tagging and genotyped using TaqMan® allele discrimination technology. RESULTS: Individual SNP metaanalysis showed no evidence of association of the 3 IL6 genetic variants with the global disease. Phenotype analyses revealed a significant association between the minor allele of rs2069840 and the limited cutaneous SSc clinical form (Bonferroni p = 0.036, OR 1.14, 95% CI 1.04-1.25). A trend of association between the minor allele of the rs1800795 and the diffuse cutaneous SSc clinical form was also evident (Bonferroni p = 0.072, OR 0.86, 95% CI 0.77-0.96). In the IL6 allelic combination analyses, the GGC allelic combination rs2069827-rs1800795-rs2069840 showed an association with overall SSc (Bonferroni p = 0.016, OR 1.13, 95% CI 1.04-1.23). CONCLUSION: Our results suggest that the IL6 gene may influence the development of SSc and its progression.}}, author = {{Cénit, Maria Carmen and Simeón, Carmen P and Vonk, Madelon C and Callejas-Rubio, Jose L and Espinosa, Gerard and Carreira, Patricia and Blanco, Francisco J and Narvaez, Javier and Tolosa, Carlos and Román-Ivorra, José A and Gómez-García, Inmaculada and García-Hernández, Francisco J and Gallego, María and Garcia Sanchez, Rosa and Egurbide, María Victoria and Fonollosa, Vicente and de la Peña, Paloma García and López-Longo, Francisco J and González-Gay, Miguel A and Hesselstrand, Roger and Riemekasten, Gabriela and Witte, Torsten and Voskuyl, Alexandre E and Schuerwegh, Annemie J and Madhok, Rajan and Fonseca, Carmen and Denton, Christopher and Nordin, Annika and Palm, Oyvind and van Laar, Jacob M and Hunzelmann, Nicolas and Distler, Jörg H W and Kreuter, Alexander and Herrick, Ariane and Worthington, Jane and Koeleman, Bobby P and Radstake, Timothy R D J and Martín, Javier}}, issn = {{0315-162X}}, language = {{eng}}, month = {{10}}, publisher = {{Journal of Rheumatology Publishing Company Limited}}, series = {{Journal of Rheumatology}}, title = {{Influence of the IL6 Gene in Susceptibility to Systemic Sclerosis.}}, url = {{http://dx.doi.org/10.3899/jrheum.120506}}, doi = {{10.3899/jrheum.120506}}, year = {{2012}}, }